A new study looked at how pharmacogenomics could improve the safety and effectiveness of COVID-19 drug therapies.
The interactive tool highlights unprecedented cross-sector collaboration
Idefirix is an immunosuppressant that reduces the level of donor specific antibodies, thus enabling transplantation
It is hoped that the vaccine will generate protection not only against SARS-CoV-2, but also against new strains […]
Blenrep is a first-line inhibitor of BCMA, a cell-surface protein that plays a crucial role in the survival […]
FDA pulls J&J’s Invokana boxed warning after reviewing amputation risks—but the sales damage is done
FDA pulls J&J’s Invokana boxed warning after reviewing amputation risks—but the sales damage is done chelfand Thu, 08/27/2020 […]
FDA balks at recalls for 2 tuberculosis meds despite possible carcinogen contamination kblankenship Thu, 08/27/2020 – 11:11
Pfizer could score fast COVID vaccine nod, thanks to Hahn’s promise of October FDA review: analyst arlene.weintraub Thu, […]
Regeneron plots 400 hires to handle increased workload amid COVID-19 cocktail production push kblankenship Thu, 08/27/2020 – 09:22
